Cambridge, MA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

How Do You Tell a Cognitively Normal Person They Will Likely Get Alzheimer’s in the Next Few Years?

As researchers seek cognitively normal people on the way to Alzheimer’s to fill clinical prevention trials, they face the delicate task of disclosing a highly elevated, but not certain, risk of developing the disease to thousands of people....
11-Sep-2016 6:05 PM EDT Add to Favorites

Eight Years Old and Growing Fast: DIAN Is Becoming an Alzheimer’s Movement

The Dominantly Inherited Alzheimer’s Network is churning out serial data on how Alzheimer’s disease develops in a given person over many years, and at the same time transforming how therapeutic trials are being done on this disease.
18-Aug-2016 12:05 PM EDT Add to Favorites

New Insights into Microglia Help Researchers Understand Neurodegenerative Disease

Alzforum reports some of the major highlights from the recent Keystone symposium on the role of microglia in neurodegenerative disease.
18-Aug-2016 12:05 PM EDT Add to Favorites

Coming to a Center Near You: GAP and EPAD to Revamp Alzheimer’s Trials

In the past year, the Global Alzheimer’s Platform and the European Prevention of Alzheimer’s Dementia have moved quickly, and jointly, to pave the way toward more, faster, cheaper trials. Will they be better, too?
15-Aug-2016 9:05 AM EDT Add to Favorites

Brexit Could Threaten Neurodegenerative Disease Research in Europe

Neurodegenerative disease researchers in the U.K. fear the Brexit will curtail their access to EU funds and complicate international collaborations. Analysts agree that a U.K. exit is likely to harm big science across the continent.
11-Jul-2016 12:05 PM EDT Add to Favorites

Fresh Insights Into Sleep, Brain Cleansing, and Memory

Researchers are making progress in understanding exactly how sleep helps the brain lay down memories and remove waste products. The findings may have implications for diseases in which sleep and memory are impaired. Alzforum reports.
23-May-2016 5:05 PM EDT Add to Favorites

Drug Trials in Frontotemporal Dementia: Can Industry, Academia, Families and Regulators Get on One Page?

In Washington, D.C., stakeholders in frontotemporal dementia came together to apply lessons learned from setbacks of Alzheimer’s drug development to the emerging field of therapy evaluation in FTD.
26-Apr-2016 1:05 PM EDT Add to Favorites

NIH Summit Sets Priorities for Research on the Non-Alzheimer’s Dementias

Last month, scientists gathered to powwow about where we are with FTD, DLB, and cerebrovascular disorders and how best to target research dollars to them. Researchers articulated funding priorities for each of these diseases, which will inform the...
21-Apr-2016 1:05 PM EDT Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.




Chat now!